Active Ingredient: TERIFLUNOMIDE
Proprietary Name: TERIFLUNOMIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 14MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A209549
Product Number: 002
Approval Date: Jul 27, 2018
Applicant Holder Full Name: WATSON LABORATORIES INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC
Marketing Status:
Discontinued
Patent and Exclusivity Information